Tautomycin's interactions with protein phosphatase 1
1Laboratory of Organic Chemistry, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8601, Japan.
Chemistry, an Asian Journal
|December 17, 2009
Summary
Tautomycin (TTM) uniquely inhibits protein phosphatase 1 (PP1) over PP2A. This review examines studies on TTM-PP1 interactions before the 2009 crystal structure, comparing early conclusions with established findings.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Tautomycin (TTM), isolated in 1987, is a unique inhibitor selective for protein phosphatase 1 (PP1) over protein phosphatase 2A (PP2A).
- Understanding the basis for TTM's PP1 selectivity has been a long-standing challenge in phosphatase research.
Purpose of the Study:
- To review and analyze research efforts aimed at elucidating the interaction mechanism between Tautomycin and PP1.
- To compare the conclusions drawn from structural and biochemical studies prior to the TTM-PP1 cocrystal structure with the actual findings revealed by the structure.
Main Methods:
- Literature review of studies investigating Tautomycin's inhibitory effects on PP1 and PP2A.
- Analysis of biochemical and biophysical data related to TTM-PP1 interactions.
- Comparative analysis of pre- and post-crystallographic structural data.
Main Results:
- Early research established TTM's preferential inhibition of PP1.
- Various studies attempted to map the binding site and understand the molecular basis of TTM's selectivity.
- The 2009 cocrystal structure provided definitive insights into the TTM-PP1 interaction.
Conclusions:
- Pre-crystallographic hypotheses regarding TTM-PP1 interaction were largely consistent with the final structural data.
- The structural elucidation confirmed the molecular basis for Tautomycin's unique selectivity for PP1.
- This review highlights the progression of scientific understanding driven by structural biology.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...